EUVIMEDEUVIMED entdecken
Open Access

Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy

He Zhang iD, Dejing Liu iD, Kang Yang iD, Zhuoying Liang, Mao Li iD

Science Advances · 24.10.2025 · 11 (43)

DOI: 10.1126/sciadv.adx5970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 24.10.2025. Verfasst von He Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Immunotherapy, Guanidine. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of lipid nanoparticle (LNP) systems has largely advanced RNA therapeutics, particularly mRNA-based cancer immunotherapy. Conventional amine-LNPs, designed for hepatic RNA delivery, face challenges in targeting lymphoid organs effectively and maximize antigen presentation. In this study, we present the development of pH-responsive ionizable guanidine-LNPs (G-LNPs). Our cholesterol-free G-LNP system enables efficient delivery of mRNA to the spleen following intravenous administration. Notably, while both amine-LNPs and G-LNPs can deliver mRNA to the spleen, G-LNPs exhibit a unique ability to preferentially target antigen-presenting cells, leading to significantly enhanced antigen presentation and robust T cell activation. mRNA vaccines formulated with G-LNPs elicited strong and antigen-specific immune responses, providing complete protection against tumor progression. In addition, intraperitoneal administration of G-LNPs enabled selective mRNA expression in the pancreas, showcasing the versatility of this delivery platform. These findings underscore the potential of guanidine-LNPs as a highly promising platform for organ-targeted mRNA delivery and cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerNanoparticlesImmunotherapyGuanidineLipidsNeoplasmsAnimalsMiceHumansCancer VaccinesCell Line, TumorLiposomes

Substanzen

RNA, MessengerGuanidineLipidsLipid NanoparticlesCancer VaccinesLiposomes

Autor:innen und Institutionen

  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.

ORCID-Profile: He Zhang, Dejing Liu, Kang Yang, Mao Li

Zitieren

APA

Zhang, H., Liu, D., Yang, K., Liang, Z., & Li, M. (2025). Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy. Science Advances, 11(43). https://doi.org/10.1126/sciadv.adx5970

Vancouver

Zhang H, Liu D, Yang K, Liang Z, Li M. Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy. Science Advances. 2025;11(43). doi:10.1126/sciadv.adx5970

BibTeX
@article{Zhang2025,
  author = {Zhang, He and Liu, Dejing and Yang, Kang and Liang, Zhuoying and Li, Mao},
  title = {Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {43},
  doi = {10.1126/sciadv.adx5970}
}
Kostenlos starten →